{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:24:08Z","timestamp":1770693848881,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia (INCT) para Controle do C\u00e2ncer: Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["573806\/2008-0\/FAPERJ E26\/170.026\/2008."],"award-info":[{"award-number":["573806\/2008-0\/FAPERJ E26\/170.026\/2008."]}]},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro (FAPERJ)","award":["E-26\/110.238\/2014."],"award-info":[{"award-number":["E-26\/110.238\/2014."]}]},{"name":"Programa de Oncobiologia\/Funda\u00e7\u00e3o do C\u00e2ncer and FAPERJ","award":["E-26\/110.375\/2014"],"award-info":[{"award-number":["E-26\/110.375\/2014"]}]},{"DOI":"10.13039\/501100013904","name":"SWISS-BRIDGE Foundation","doi-asserted-by":"crossref","award":["1B\/2014"],"award-info":[{"award-number":["1B\/2014"]}],"id":[{"id":"10.13039\/501100013904","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00277-016-2653-7","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T23:57:46Z","timestamp":1459814266000},"page":"881-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis"],"prefix":"10.1007","volume":"95","author":[{"given":"Marcela Cristina","family":"Robaina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta Soares","family":"Faccion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Mazzoccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia Maria M.","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Queiroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Thomas-Tikhonenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudete Esteves","family":"Klumb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"issue":"1","key":"2653_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV (2012) MYC on the path to cancer. Cell 149(1):22\u201335. doi: 10.1016\/j.cell.2012.03.003","journal-title":"Cell"},{"issue":"4","key":"2653_CR2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","volume":"16","author":"CV Dang","year":"2006","unstructured":"Dang CV, O\u2019Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F (2006) The c-Myc target gene network. Semin Cancer Biol 16(4):253\u2013264. doi: 10.1016\/j.semcancer.2006.07.014","journal-title":"Semin Cancer Biol"},{"issue":"7043","key":"2653_CR3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043):839\u2013843. doi: 10.1038\/nature03677","journal-title":"Nature"},{"issue":"4","key":"2653_CR4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S1097-2765(03)00102-3","volume":"11","author":"TA Baudino","year":"2003","unstructured":"Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A et al (2003) Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell 11(4):905\u2013914","journal-title":"Mol Cell"},{"issue":"1","key":"2653_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al (2008) Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40(1):43\u201350. doi: 10.1038\/ng.2007.30","journal-title":"Nat Genet"},{"issue":"23","key":"2653_CR6","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1182\/blood-2010-10-315432","volume":"117","author":"MJ Bueno","year":"2011","unstructured":"Bueno MJ, Gomez de Cedron M, Gomez-Lopez G, Perez de Castro I, Di Lisio L, Montes-Moreno S et al (2011) Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway. Blood 117(23):6255\u20136266. doi: 10.1182\/blood-2010-10-315432","journal-title":"Blood"},{"issue":"2","key":"2653_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215\u2013233. doi: 10.1016\/j.cell.2009.01.002","journal-title":"Cell"},{"key":"2653_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8722-5-7","volume":"5","author":"TR Fernando","year":"2012","unstructured":"Fernando TR, Rodriguez-Malave NI, Rao DS (2012) MicroRNAs in B cell development and malignancy. J Hematol Oncol 5:7. doi: 10.1186\/1756-8722-5-7","journal-title":"J. Hematol. Oncol."},{"issue":"5A","key":"2653_CR9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1582-4934.2008.00399.x","volume":"12","author":"CH Lawrie","year":"2008","unstructured":"Lawrie CH (2008) MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? J Cell Mol Med 12(5A):1432\u20131444. doi: 10.1111\/j.1582-4934.2008.00399.x","journal-title":"J Cell Mol Med"},{"issue":"5","key":"2653_CR10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","volume":"29","author":"K Musilova","year":"2015","unstructured":"Musilova K, Mraz M (2015) MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia 29(5):1004\u20131017. doi: 10.1038\/leu.2014.351","journal-title":"Leukemia"},{"issue":"8","key":"2653_CR11","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/nar\/gki567","volume":"33","author":"Y Altuvia","year":"2005","unstructured":"Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A et al (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33(8):2697\u20132706. doi: 10.1093\/nar\/gki567","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2653_CR12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jmb.2004.03.065","volume":"339","author":"A Tanzer","year":"2004","unstructured":"Tanzer A, Stadler PF (2004) Molecular evolution of a microRNA cluster. J Mol Biol 339(2):327\u2013335. doi: 10.1016\/j.jmb.2004.03.065","journal-title":"J Mol Biol"},{"issue":"1","key":"2653_CR13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/imr.12054","volume":"253","author":"V Olive","year":"2013","unstructured":"Olive V, Li Q, He L (2013) miR-17-92: a polycistronic oncomir with pleiotropic functions. Immunol Rev 253(1):158\u2013166. doi: 10.1111\/imr.12054","journal-title":"Immunol Rev"},{"issue":"7043","key":"2653_CR14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834\u2013838. doi: 10.1038\/nature03702","journal-title":"Nature"},{"issue":"4","key":"2653_CR15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","volume":"9","author":"C Xiao","year":"2008","unstructured":"Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J et al (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9(4):405\u2013414. doi: 10.1038\/ni1575","journal-title":"Nat Immunol"},{"issue":"17","key":"2653_CR16","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/emboj.2013.178","volume":"32","author":"HY Jin","year":"2013","unstructured":"Jin HY, Oda H, Lai M, Skalsky RL, Bethel K, Shepherd J et al (2013) MicroRNA-17\u223c92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J 32(17):2377\u20132391. doi: 10.1038\/emboj.2013.178","journal-title":"EMBO J"},{"issue":"5","key":"2653_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ et al (2008) Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132(5):875\u2013886. doi: 10.1016\/j.cell.2008.02.019","journal-title":"Cell"},{"issue":"24","key":"2653_CR18","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A 79(24):7824\u20137827","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2653_CR19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1365-2141.2010.08111.x","volume":"149","author":"JL Robertus","year":"2010","unstructured":"Robertus JL, Kluiver J, Weggemans C, Harms G, Reijmers RM, Swart Y et al (2010) MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 149(6):896\u2013899. doi: 10.1111\/j.1365-2141.2010.08111.x","journal-title":"Br J Haematol"},{"issue":"2","key":"2653_CR20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ccr.2014.06.014","volume":"26","author":"Y Li","year":"2014","unstructured":"Li Y, Choi PS, Casey SC, Dill DL, Felsher DW (2014) MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. Cancer Cell 26(2):262\u2013272. doi: 10.1016\/j.ccr.2014.06.014","journal-title":"Cancer Cell"},{"issue":"19","key":"2653_CR21","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117(19):5019\u20135032. doi: 10.1182\/blood-2011-01-293050","journal-title":"Blood"},{"issue":"3","key":"2653_CR22","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7(3):332\u2013339","journal-title":"Semin Oncol"},{"issue":"7","key":"2653_CR23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00043426-200407000-00014","volume":"26","author":"CE Klumb","year":"2004","unstructured":"Klumb CE, Schramm MT, De Resende LM, Carrico MK, Coelho AM, de Meis E et al (2004) Treatment of children with B-cell non-Hodgkin\u2019s lymphoma in developing countries: the experience of a single center in Brazil. J Pediatr Hematol Oncol 26(7):462\u2013468","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"2653_CR24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ijc.11443","volume":"108","author":"CE Klumb","year":"2004","unstructured":"Klumb CE, Hassan R, De Oliveira DE, De Resende LM, Carrico MK, De Almeida DJ et al (2004) Geographic variation in Epstein-Barr virus-associated Burkitt\u2019s lymphoma in children from Brazil. Int J Cancer: Journal international du cancer 108(1):66\u201370. doi: 10.1002\/ijc.11443","journal-title":"Int. J. Cancer: Journal international du cancer"},{"issue":"6","key":"2653_CR25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1309\/AJCP64YOHAWLUMPK","volume":"130","author":"EM Queiroga","year":"2008","unstructured":"Queiroga EM, Gualco G, Weiss LM, Dittmer DP, Araujo I, Klumb CE et al (2008) Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features. Am J Clin Pathol 130(6):946\u2013956. doi: 10.1309\/AJCP64YOHAWLUMPK","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"2653_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25(4):402\u2013408. doi: 10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"26","key":"2653_CR27","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2012-12-473090","volume":"122","author":"JN Psathas","year":"2013","unstructured":"Psathas JN, Doonan PJ, Raman P, Freedman BD, Minn AJ, Thomas-Tikhonenko A (2013) The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop. Blood 122(26):4220\u20134229. doi: 10.1182\/blood-2012-12-473090","journal-title":"Blood"},{"issue":"282","key":"2653_CR28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric-estimation from incomplete observations. J Am Stat Assoc 53(282):457\u2013481. doi: 10.2307\/2281868","journal-title":"J Am Stat Assoc"},{"issue":"5","key":"2653_CR29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagrm.2014.12.006","volume":"1849","author":"B Majello","year":"2015","unstructured":"Majello B, Perini G (2015) Myc proteins in cell biology and pathology. Biochim Biophys Acta 1849(5):467\u2013468. doi: 10.1016\/j.bbagrm.2014.12.006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2653_CR30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbrc.2006.07.207","volume":"349","author":"J Yu","year":"2006","unstructured":"Yu J, Wang F, Yang GH, Wang FL, Ma YN, Du ZW et al (2006) Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. Biochem Biophys Res Commun 349(1):59\u201368. doi: 10.1016\/j.bbrc.2006.07.207","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2653_CR31","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","volume":"64","author":"A Ota","year":"2004","unstructured":"Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al (2004) Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64(9):3087\u20133095","journal-title":"Cancer Res"},{"issue":"11","key":"2653_CR32","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/sj.leu.2403942","volume":"19","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Seto M (2005) A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19(11):2013\u20132016. doi: 10.1038\/sj.leu.2403942","journal-title":"Leukemia"},{"issue":"4","key":"2653_CR33","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1074\/jbc.M608939200","volume":"282","author":"Y Sylvestre","year":"2007","unstructured":"Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F et al (2007) An E2F\/miR-20a autoregulatory feedback loop. J Biol Chem 282(4):2135\u20132143. doi: 10.1074\/jbc.M608939200","journal-title":"J Biol Chem"},{"issue":"8","key":"2653_CR34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.biocel.2010.03.004","volume":"42","author":"V Olive","year":"2010","unstructured":"Olive V, Jiang I, He L (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42(8):1348\u20131354. doi: 10.1016\/j.biocel.2010.03.004","journal-title":"Int J Biochem Cell Biol"},{"issue":"7043","key":"2653_CR35","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043):828\u2013833. doi: 10.1038\/nature03552","journal-title":"Nature"},{"issue":"7418","key":"2653_CR36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M et al (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116\u2013120. doi: 10.1038\/nature11378","journal-title":"Nature"},{"issue":"7","key":"2653_CR37","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","volume":"125","author":"J Iqbal","year":"2015","unstructured":"Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C et al (2015) Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. Blood 125(7):1137\u20131145. doi: 10.1182\/blood-2014-04-566778","journal-title":"Blood"},{"key":"2653_CR38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00822","volume":"2","author":"V Olive","year":"2013","unstructured":"Olive V, Sabio E, Bennett MJ, De Jong CS, Biton A, McGann JC et al (2013) A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis. eLife 2, e00822. doi: 10.7554\/eLife.00822","journal-title":"eLife"},{"key":"2653_CR39","doi-asserted-by":"crossref","unstructured":"Lai M, Xiao C (2015) Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation. Int. Immunol. doi: 10.1016\/j.intimp.2015.03.041 .","DOI":"10.1016\/j.intimp.2015.03.041"},{"issue":"12","key":"2653_CR40","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1349-7006.2011.02081.x","volume":"102","author":"A Tsuchida","year":"2011","unstructured":"Tsuchida A, Ohno S, Wu W, Borjigin N, Fujita K, Aoki T et al (2011) miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci 102(12):2264\u20132271. doi: 10.1111\/j.1349-7006.2011.02081.x","journal-title":"Cancer Sci"},{"issue":"16","key":"2653_CR41","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","volume":"101","author":"A Egle","year":"2004","unstructured":"Egle A, Harris AW, Bouillet P, Cory S (2004) Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci U S A 101(16):6164\u20136169. doi: 10.1073\/pnas.0401471101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2653_CR42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","volume":"109","author":"C Mestre-Escorihuela","year":"2007","unstructured":"Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V et al (2007) Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 109(1):271\u2013280. doi: 10.1182\/blood-2006-06-026500","journal-title":"Blood"},{"issue":"2","key":"2653_CR43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1182\/blood-2008-07-163907","volume":"113","author":"M Inomata","year":"2009","unstructured":"Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K (2009) MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113(2):396\u2013402. doi: 10.1182\/blood-2008-07-163907","journal-title":"Blood"},{"key":"2653_CR44","doi-asserted-by":"crossref","unstructured":"Psathas JN, Thomas-Tikhonenko A (2014) MYC and the art of microRNA maintenance. Cold Spring Harbor perspectives in medicine. 4(8). doi: 10.1101\/cshperspect.a014175 .","DOI":"10.1101\/cshperspect.a014175"},{"issue":"8","key":"2653_CR45","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A et al (2005) Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24(8):1348\u20131358. doi: 10.1038\/sj.onc.1208300","journal-title":"Oncogene"},{"issue":"4","key":"2653_CR46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.onc.1210668","volume":"27","author":"E Anderton","year":"2008","unstructured":"Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ (2008) Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt\u2019s lymphoma. Oncogene 27(4):421\u2013433. doi: 10.1038\/sj.onc.1210668","journal-title":"Oncogene"},{"issue":"6","key":"2653_CR47","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2010-05-285791","volume":"117","author":"DT Vereide","year":"2011","unstructured":"Vereide DT, Sugden B (2011) Lymphomas differ in their dependence on Epstein-Barr virus. Blood 117(6):1977\u20131985. doi: 10.1182\/blood-2010-05-285791","journal-title":"Blood"},{"issue":"6","key":"2653_CR48","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2141.2012.09243.x","volume":"158","author":"V Leventaki","year":"2012","unstructured":"Leventaki V, Rodic V, Tripp SR, Bayerl MG, Perkins SL, Barnette P et al (2012) TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases. Br J Haematol 158(6):763\u2013771. doi: 10.1111\/j.1365-2141.2012.09243.x","journal-title":"Br J Haematol"},{"issue":"4","key":"2653_CR49","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","volume":"28","author":"B Pienkowska-Grela","year":"2011","unstructured":"Pienkowska-Grela B, Rymkiewicz G, Grygalewicz B, Woroniecka R, Krawczyk P, Czyz-Domanska K et al (2011) Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement. Med Oncol 28(4):1589\u20131595. doi: 10.1007\/s12032-010-9614-0","journal-title":"Med Oncol"},{"issue":"8","key":"2653_CR50","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J et al (2014) A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood 123(8):1187\u20131198. doi: 10.1182\/blood-2013-06-507996","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2653-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2653-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T17:51:23Z","timestamp":1589651483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2653"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2653-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}